JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-9. Extranodal NK/T-cell lymphoma, nasal type (ENKL) Motoko YamaguchiRitsuro Suzuki Guide Line 28 February 2019 Pages: 371 - 376
Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry Hiroyuki TakamatsuTakeshi YoroidakaKosei Matsue Rapid Communication 18 February 2019 Pages: 377 - 381
Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency Eri KumakiKeisuke TanakaTomohiro Morio Original Article 13 February 2019 Pages: 382 - 389
Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation Shoko FurukawaKeiji NogamiMidori Shima Original Article 13 February 2019 Pages: 390 - 401
Clinical features at transformation in adult T-cell leukemia–lymphoma with smoldering and chronic types Hiroaki TaniguchiYoshitaka ImaizumiYasushi Miyazaki Original Article 24 January 2019 Pages: 402 - 408
Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) Hirokazu MurakamiTetsuhiro KasamatsuKazuyuki Shimizu Original Article 31 January 2019 Pages: 409 - 417
Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia Nahoko HatsumiShuichi MiyawakiThe Japan Adult Leukemia Study Group (JALSG) Original Article 06 February 2019 Pages: 418 - 425
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system Masahiro KizakiNaoto Takahashithe New TARGET investigators Original Article 14 February 2019 Pages: 426 - 439
Optimal dosage of methotrexate for GVHD prophylaxis in umbilical cord blood transplantation Yoshitaka AdachiKazutaka OzekiAkio Kohno Original Article 24 January 2019 Pages: 440 - 450
Prognostic values of increased B7 family proteins in haploidentical hematopoietic stem cell transplantation patients with aGVHD Biqi ZhouTanzhen WangDepei Wu Original Article 06 February 2019 Pages: 451 - 462
Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen Takumi HoshinoSatoru TakadaToru Sakura Original Article 08 February 2019 Pages: 463 - 469
Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index Yasufumi KawasakiShun-ichi KimuraYoshinobu Kanda Original Article 25 January 2019 Pages: 470 - 476
Discontinuation of l-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia Ikuya UsamiToshihiko ImamuraJapan Association of Childhood Leukemia Study Group (JACLS) Original Article 28 January 2019 Pages: 477 - 482
Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma Naoto FujitaRyoji KobayashiTetsuo Mitsui Original Article 30 January 2019 Pages: 483 - 490
Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan Nozomu KawashimaMinako IidaKoji Kato Original Article 29 January 2019 Pages: 491 - 498
A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide Wataru KishimotoYoko TakiuchiNobuyoshi Arima Case Report 02 January 2019 Pages: 499 - 504
Correction to: Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry Hiroyuki TakamatsuTakeshi YoroidakaKosei Matsue Correction 21 March 2019 Pages: 505 - 505